Document is current
Any future updates will be listed below
-
Authors
Atlas, Steven J. https://orcid.org/0000-0002-2297-9614
Borowsky, Leila H.
Chang, Yuchiao
Ashburner, Jeffrey M.
Ellinor, Patrick T.
Lubitz, Steven A.
Singer, Daniel E.
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb (2017P000562)
- License Information
-
More Information
Article History
Received: 24 October 2023
Accepted: 15 March 2024
First Online: 2 April 2024
Declarations:
:
: Dr. Atlas has received sponsored research support from Bristol Myers Squibb / Pfizer and American Heart Association (18SFRN34250007). Dr. Atlas has consulted for Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, and Fitbit. Dr. Ashburner is supported by NIH grant K01HL148506, American Heart Association 18SFRN34250007, and has received sponsored research support from Bristol Myers Squibb / Pfizer. Dr. Ellinor is supported by grants from the National Institutes of Health (RO1HL092577, RO1HL157635), by a grant from the American Heart Association (18SFRN34110082, 961045), and by a grant from the European Union (MAESTRIA 965286). Dr. Ellinor receives sponsored research support from Bayer AG and Novo Nordisk; he has also served on advisory boards or consulted for Bayer AG. Dr. Lubitz is an employee of Novartis. Dr. Lubitz was previously supported by NIH grants R01HL139731 and R01HL157635, and American Heart Association 18SFRN34250007. Dr. Lubitz received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM, and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae. Dr. Singer is supported, in part, by the Eliot B. and Edith C. Shoolman Fund of Massachusetts General Hospital. Dr. Singer receives research support from Bristol Myers Squibb-Pfizer and has received consulting fees from Bristol Myers Squibb, Fitbit (Google), Medtronic, and Pfizer. The remaining authors have nothing to disclose.
Free to read: This content has been made available to all.
